Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

AppLovin 3Q26 Business Update: No Notes

AppLovin’s Q3 revenue rose 55% year over year as AXON model gains expanded margins, while ad take-rate compression remains the key competitive risk.

APP $118B
Speedwell Research 3 clicks

From X

@aleabitoreddit

Serenity on X

For companies like $SIVE / $AAOI, the demand imbalance for lasers are so severe That even a 20-30% overall demand reduction from a hypothetical DC slowdown would likely not eliminate the shortage. We're seeing this before the next architectural shifts, where $NVDA Jensen Huang expects 15x optical volume for CPO scale-up. And as more hyperscalers commit to NPO as seen with $LITE new $5B UHP laser contracts. I'd argue this is more nuanced since I can't say the same for finished 800G/1.6T pluggables or lower end 70mW-100mW laser ranges that are currently bottlenecks. But this argument is more toward higher spec lasers. $AAOI is vertically integrated and has 300-400 mW capabilities, so they have the capability to shift attention to merchant lasers over supplying end-to-end optical transceivers. $SIVE is more pure play on this laser bottleneck, but they have the capabilities for 200mW + higher margin multiwavelength NPO/CPO lasers. I'd argue this is specifically the case for bottlenecks where demand imbalances are so deep (creating higher long term visibility, such as HBM). Whether it's large body substrates from $ATS that's bottlenecking Marvell + $AMD or lasers from $LITE that are sold out into 2029. or liquid transformers that have 4-5 year lead times. They they would still sell out of capacity even if overall demand decreased. If markets de-risked, it would make sense to hit optical module manufacturing players, maybe server rack assembly, to companies that still require heavy financing like Neoclouds. And obviously haircut growth valuations (but not to the point where demand collapses to 0). Yet we're seeing everything in AI trade is getting lumped up together as something that requires heavy financing + not profitable.
@aleabitoreddit 1 click

Serenity on X

If a company is valued at $2B, has ~$1B in cash/inventory... And makes $354M FCF a quarter. Then returns 30-50% of FCF for dividends next year. I'd argue it's more of a matter of time before shareholder returns/fundamentals, (especially memory) overpower forced selling. But stock prices can look really dislocated from actual performance for periods of time, like now. Same with photonics, but that's more of a 2027-2028 growth type story with CPO + more optical content/xpu. Laser companies like $LITE, $AAOI, and potentially $SIVE depending on quals, would likely be printing few years after capacity expansion comes online. And it's already been largely funded... Lumentum with $NVDA + hyperscalers, AOI with $1.6B+ in ATMs, Sivers with 700M SEK from institutions. Compared to other sectors that still require a lot of capital for their buildouts.
@ActAccordingly

PAA Research on X

Not a surprise, but still encouraging. The Zelda remake from $NTDOY has a 96 right now on metacritic. It comes out today. No one seems to talk about 7974/$NTDOY because there's no Mario title this year, but putting out a remake of arguably the best video game ever made and then matching its excellence in front of a major motion picture release seems like it's good for revenue, earnings, and cash flow. I don't think investors understand the #zelda fan base. or maybe #nintendo in its entirety. @firstadopter

Investor Letters

All letters

Trading Post November 5, 2026

MercadoLibre’s logistics expansion cut margins by 60 basis points, while Mercado Pago grew credit 62% with 7% NPLs.

MELI $77B
Cassandra Unchained 2 clicks

Intel: The CPU Comeback, Discounted

Intel's Q3 2026 results were hit by memory costs and an Israel shutdown, but enterprise AI inference could lift CPU demand as server…

INTC $287B
Monte Independent Investment Research 2 clicks

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Oracle: The Party Is Almost Over

Oracle’s CDS spreads exceed 320 basis points as debt approaches $135 billion and fiscal 2027 capex targets $95 billion, amid heavy reliance…

ORCL $363B
David Desjardins 1 click

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 276

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.